Xbiotech Inc
(XBIT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 147,367 | 152,938 | 155,897 | 172,677 | 183,118 |
| Receivables | 525 | 638 | 638 | 858 | 871 |
| TOTAL | $148,951 | $154,889 | $157,685 | $174,567 | $185,034 |
| Non-Current Assets | |||||
| PPE Net | 23,473 | 23,793 | 24,179 | 24,526 | 24,817 |
| TOTAL | $23,473 | $23,793 | $24,179 | $24,526 | $24,817 |
| Total Assets | $172,424 | $178,682 | $181,864 | $199,093 | $209,851 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 10,250 | 10,000 |
| Accounts payable and accrued liabilities | 1,043 | 1,431 | 1,100 | 2,223 | 1,506 |
| Accrued Expenses | 2,422 | 2,410 | 4,303 | 2,632 | 4,486 |
| TOTAL | $3,565 | $3,857 | $5,410 | $15,105 | $15,992 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,779 | 1,761 | 1,741 | 1,720 | 1,744 |
| TOTAL | $1,779 | $1,761 | $1,741 | $1,720 | $1,744 |
| Total Liabilities | $5,344 | $5,618 | $7,151 | $16,825 | $17,736 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 30,488 | 30,488 | 30,488 | 30,488 | 30,483 |
| Common Shares | 276,565 | 276,541 | 276,434 | 273,105 | 272,444 |
| Retained earnings | -109,485 | -103,477 | -101,721 | -90,837 | -80,329 |
| TOTAL | $167,080 | $173,064 | $174,713 | $182,268 | $192,115 |
| Total Liabilities And Equity | $172,424 | $178,682 | $181,864 | $199,093 | $209,851 |